A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians.

IF 1.1 Q4 PHARMACOLOGY & PHARMACY Translational and Clinical Pharmacology Pub Date : 2023-06-01 Epub Date: 2023-06-26 DOI:10.12793/tcp.2023.31.e9
Kyungmee Choi
{"title":"A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians.","authors":"Kyungmee Choi","doi":"10.12793/tcp.2023.31.e9","DOIUrl":null,"url":null,"abstract":"<p><p>This article reviews the Bayesian inference with the Monte Carlo Markov Chain (MCMC) and the Hamiltonian Monte Carlo (HMC) samplers as a competitor of the classical likelihood statistical inference for pharmacometricians. The MCMC and the HMC samplers have greatly contributed to realization of the Bayesian methods with minimal requirement of mathematical theory. They do not require any closed form of the posterior density nor linear approximation of complex nonlinear models in high dimension even with non-conjugate priors. The HMC even weakens the dependency of the chain and improves computational efficiency. Pharmacometrics is one of great beneficiaries since they use complex multivariate multilevel nonlinear mixed effects models based on the restricted maximum likelihood estimation. Comprehension of the Bayesian approach will help pharmacometricians to access the data analysis more conveniently.</p>","PeriodicalId":23288,"journal":{"name":"Translational and Clinical Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/0d/tcp-31-69.PMC10333649.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational and Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12793/tcp.2023.31.e9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

This article reviews the Bayesian inference with the Monte Carlo Markov Chain (MCMC) and the Hamiltonian Monte Carlo (HMC) samplers as a competitor of the classical likelihood statistical inference for pharmacometricians. The MCMC and the HMC samplers have greatly contributed to realization of the Bayesian methods with minimal requirement of mathematical theory. They do not require any closed form of the posterior density nor linear approximation of complex nonlinear models in high dimension even with non-conjugate priors. The HMC even weakens the dependency of the chain and improves computational efficiency. Pharmacometrics is one of great beneficiaries since they use complex multivariate multilevel nonlinear mixed effects models based on the restricted maximum likelihood estimation. Comprehension of the Bayesian approach will help pharmacometricians to access the data analysis more conveniently.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
综述贝叶斯方法与 MCMC 和 HMC,作为药物计量学经典似然统计的竞争对手。
本文综述了蒙特卡洛马尔可夫链(MCMC)和汉密尔顿蒙特卡洛(HMC)采样器的贝叶斯推断方法,它们是药物计量学经典似然统计推断方法的竞争对手。MCMC 和 HMC 采样器极大地促进了贝叶斯方法的实现,对数学理论的要求极低。它们不需要后验密度的任何封闭形式,也不需要对高维度复杂非线性模型进行线性近似,甚至不需要非共轭先验。HMC 甚至可以弱化链的依赖性,提高计算效率。药物计量学就是其中的一大受益者,因为它们使用基于受限极大似然估计的复杂多变量多层次非线性混合效应模型。对贝叶斯方法的理解将有助于药物计量学家更方便地进行数据分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Translational and Clinical Pharmacology
Translational and Clinical Pharmacology Medicine-Pharmacology (medical)
CiteScore
1.60
自引率
11.10%
发文量
17
期刊介绍: Translational and Clinical Pharmacology (Transl Clin Pharmacol, TCP) is the official journal of the Korean Society for Clinical Pharmacology and Therapeutics (KSCPT). TCP is an interdisciplinary journal devoted to the dissemination of knowledge relating to all aspects of translational and clinical pharmacology. The categories for publication include pharmacokinetics (PK) and drug disposition, drug metabolism, pharmacodynamics (PD), clinical trials and design issues, pharmacogenomics and pharmacogenetics, pharmacometrics, pharmacoepidemiology, pharmacovigilence, and human pharmacology. Studies involving animal models, pharmacological characterization, and clinical trials are appropriate for consideration.
期刊最新文献
Development of in-silico drug cardiac toxicity evaluation system with consideration of inter-individual variability. Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegoprazan orally disintegrating tablet (ODT) administered via nasogastric tube or oral dosing. Pharmacokinetics and bioequivalence study of candesartan cilexetil tablet in Chinese volunteers under fasting condition: an open-label, randomized-sequence, 2-period crossover study. Data science through natural language with ChatGPT's Code Interpreter. Emerging and upcoming therapies in insomnia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1